An Open-Label, Randomized, Crossover, Repeat-Dose Study to Evaluate the Steady-State Pharmacokinetic Profile of the Final Fixed Dose Combination (FDC) Formulation of COREG CR and Lisinopril as Compared to COREG CR in Subjects With Essential Hypertension.
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2010
At a glance
- Drugs Carvedilol/lisinopril (Primary) ; Carvedilol
- Indications Essential hypertension
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 20 May 2009 Actual initiation date changed from Sep 2007 to Oct 2007 as reported by ClinicalTrials.gov.
- 11 Oct 2007 New trial record.